Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sana Biotechnology

Sana Biotechnology
2018 FOUNDED
PRIVATE STATUS
Series A2 LATEST DEAL TYPE
$219M LATEST DEAL AMOUNT
5 INVESTORS
Description

Developer of engineered cells intended to be used as medicine for patients. The company's engineered cells can create a new class of medicines to treat a broad array of diseases, enabling patients to have access to new and meaningful medicines.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
  • 1616 Eastlake Avenue East
  • Suite 360
  • Seattle, WA 98102
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sana Biotechnology’s full profile, request a free trial.

Sana Biotechnology Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A2) 12-Feb-2019 $219M 00000 Completed Startup
1. Early Stage VC (Series A1) 11-Sep-2018 000.00 000.00 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sana Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 00,000,000 00.000000 00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Sana Biotechnology Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
WRF Capital Venture Capital Minority 000 0000 000000 0
Altitude Life Science Ventures Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Flagship Pioneering Venture Capital Minority 000 0000 000000 0
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0

Sana Biotechnology Executive Team (11)

Name Title Board
Seat
Contact
Info
Steven Harr MD Co-Founder, Board Member, Chief Executive Officer & President
Nate Hardy Chief Financial Officer
Andy May Chief Technology Officer
Sunil Agarwal MD Chief Development Officer & Head of Portfolio Strategy
Chad Cowan Ph.D Chief Scientific Officer
You’re viewing 5 of 11 executives. Get the full list »

Sana Biotechnology Board Members (10)

Name Representing Role Since Contact
Info
Donald Payan MD Sana Biotechnology Board Member 000 0000
Geoffrey von Maltzahn Ph.D Flagship Pioneering Board Member 000 0000
Hans Bishop Sana Biotechnology Co-Founder & Executive Chairman 000 0000
Noubar Afeyan Ph.D Self Co-Founder & Board Member 000 0000
Pat Yang Ph.D Sana Biotechnology Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »